Michaël Dillen is a seasoned professional in global mergers and acquisitions, business development, and corporate law. Currently serving as Global M&A and Business Development at Fagron since January 2024, Michaël also holds the position of Director at ProjectPhi since 2018. Previous roles include Chief Business Officer and Corporate Secretary at Oxurion NV from March 2020 to December 2023, as well as Chief Business Officer at Oncurious NV until June 2023. Michaël's experience extends to notable positions such as VP Corporate Development and Secretary of the Board at Mithra Pharmaceuticals from January 2017 to February 2020, and Sr. Corporate Counsel EMEA at Terumo Medical Corporation from 2014 to 2017. Michaël began a legal career as a lawyer at Dewallens & partners (2010-2014) and Assolex (2008-2009). Educational qualifications include an Executive M.Sc. in Business Administration from Saïd Business School, University of Oxford, and two Master of Laws degrees in Commercial and Business Law from Queen Mary University of London and the University of Antwerp, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices